We observed significant differences when grouping patients by sex (p < 0.001), cigarette smoking (p < 0.001), and cell differentiation (p = 0.001) in the patients with lung adenocarcinoma with the EGFR wild-type and those with the EGFR mutation type (Table 1). The gene discussed is EGFR; the disease is lung adenocarcinoma.